Login / Signup

Dupilumab therapy in children aged 2 to 12 years with uncontrolled moderate-to-severe atopic dermatitis: a Chinese real-world study.

Bingjing ZhouCong PengQiaozhi CaoJiayi WangXiang ChenRunqiu Liu
Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Keyphrases
  • atopic dermatitis
  • early onset
  • high intensity
  • stem cells
  • mesenchymal stem cells
  • bone marrow
  • smoking cessation